Ruimaite released its 2026 half-year report. First-half net profit attributable to the parent was 127 million yuan, down 3.6% year on year. Operating revenue was 763 million yuan, up 40.3% year on year. Net profit attributable to the parent after deducting non-recurring items was 118 million yuan, up 19.2% year on year. Net operating cash flow was 132 million yuan, up 49.0% year on year. Earnings per share were 1.02 yuan. In the second quarter, operating revenue was 454 million yuan, up 63.0% year on year. Net profit attributable to the parent was 88.15 million yuan, up 48.4% year on year. Net profit attributable to the parent after deducting non-recurring items was 85.25 million yuan, up 117.9% year on year. As of the end of the second quarter, total assets were 3.587 billion yuan, up 6.0% from the end of the previous year. Net assets attributable to the parent were 3.059 billion yuan, up 0.9% from the end of the previous year. The company's main business focuses on medical devices and consumables in the respiratory health field, including home non-invasive ventilators, ventilation masks and other products. It has initially completed the construction of a platform covering home use, medical use and chronic disease management, while continuing to invest in technology research and development and expand into international markets.
BMC Medical Co. Ltd. ANet profit attributable to parent fell 3.6% YoY, but revenue and adjusted profit rose strongly; mixed earnings report.